No definition available.
Fetus and newborn affected by complications of placenta, cord and membranes
P16_FET_NEWB_COMPLICATIO_PLACEN_CORD_MEMBRANES
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
70 |
4. Check minimum number of eventsNone |
70 |
5. Include endpointsNone |
70 |
6. Filter based on genotype QC (FinnGen only) |
56 |
Control definitions (FinnGen only)
- Control exclude
- P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P0[0-4]
- Name in latin
- Fetus et neonatus complicationibus placentae, funiculi umbilicalis et membranarum fetalium affectus
Similar endpoints
↥List of similar endpoints to
Fetus and newborn affected by complications of placenta, cord and membranes
based on the number of shared cases.
Similar with more cases:
- Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3567 | 1640 | 1924 |
| Only index persons | 1327 | 609 | 718 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.05 |
| Only index persons | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 0.03 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 56 | 30 | 26 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 70
- Matched controls
- 700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P02.1
ICD-10 Finland
Fetus and newborn affected by other forms of placental separation and haemorrhage
+∞
29.2
26
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
20.8
16.1
24
17
P02.7
ICD-10 Finland
Fetus and newborn affected by chorioamnionitis
+∞
15.1
14
*
P07.3
ICD-10 Finland
Other preterm infants
18.2
13.5
21
16
P21.0
ICD-10 Finland
Severe birth asphyxia
128.5
10.7
11
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
38.3
8.3
10
*
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
22.9
7.4
10
5
WX722
NOMESCO Finland
PEEP
10.9
6.6
12
13
Z3229
NOMESCO Finland
Other healthcare associate professional
5.0
6.5
16
39
P07.2
ICD-10 Finland
Extreme immaturity
+∞
6.3
6
*
P02.6
ICD-10 Finland
Fetus and newborn affected by other and unspecified conditions of umbilical cord
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
6
7
9.22
3.33
1.0
1.0
128.00
120.86
%
—
6
7
6
9
7.16
2.93
1.0
1.0
—
—
—
0
0
13
57
2.57
2.13
1.4
1.4
25.20
21.09
nmol/l
—
8
49
6
16
4.00
1.98
1.7
1.5
—
—
—
0
0
25
152
2.00
1.91
2.2
3.5
—
—
—
0
0
10
40
2.74
1.75
3.7
7.4
142.90
161.72
%
—
10
40
39
282
1.86
1.75
1.8
2.0
—
—
—
0
0
5
13
4.05
1.74
1.8
2.3
—
—
—
0
0
13
63
2.31
1.73
1.5
1.6
—
—
—
0
0
34
239
1.82
1.64
17.7
16.1
1.22
1.23
mmol/l
0.45
34
224
20
118
1.97
1.64
2.4
3.1
—
—
—
0
0
7
26
2.87
1.63
5.9
2.7
5.33
5.12
pmol/l
—
7
21
7
27
2.76
1.56
2.1
1.6
—
—
—
0
0
7
27
2.76
1.56
2.1
1.6
—
—
—
0
0
5
15
3.50
1.55
1.8
2.4
—
—
—
0
0
9
41
2.37
1.43
1.9
1.5
267.89
326.15
mu/l
—
9
41
9
43
2.25
1.36
3.9
2.3
—
—
—
0
0
9
43
2.25
1.36
3.9
2.2
—
—
—
0
0
6
24
2.64
1.33
2.2
1.8
—
—
—
0
0
27
187
1.72
1.31
4.0
5.4
—
—
—
0
0
5
18
2.91
1.31
1.8
2.2
—
—
—
0
0
5
19
2.75
1.23
1.4
1.9
—
—
—
0
0
5
20
2.61
1.17
1.8
2.1
—
—
—
0
0
5
20
2.61
1.17
1.8
2.1
—
—
—
0
0
5
22
2.37
1.05
1.8
2.0
—
—
—
0
0
5
22
2.37
1.05
1.8
2.0
—
—
—
0
0
5
22
2.37
1.05
1.8
2.4
—
—
—
0
0
5
22
2.37
1.05
1.8
2.0
—
—
—
0
0
11
62
1.92
1.01
3.4
2.1
—
—
—
0
0
9
51
1.88
0.99
4.7
8.7
85.67
85.37
%
—
9
51
9
51
1.88
0.99
3.4
1.8
—
—
—
0
0
18
120
1.67
0.98
26.3
15.1
4.93
4.90
kpa
0.11
18
114
7
37
1.99
0.97
1.4
1.5
—
—
—
0
0
27
201
1.56
0.95
3.2
3.0
—
—
—
0
0
23
165
1.59
0.94
3.7
5.0
0.20
0.24
e6/l
0.06
18
121
17
114
1.65
0.90
3.3
4.4
0.94
0.51
e6/l
0.38
12
67
43
362
1.49
0.81
6.3
9.7
3.00
3.48
e9/l
1.22
35
299
5
23
2.26
0.78
1.2
1.6
—
—
—
0
0
5
26
1.99
0.72
2.0
1.8
—
—
—
0
0
52
462
1.49
0.69
4.3
3.6
1.91
2.09
mu/l
0.66
46
428
16
114
1.52
0.66
28.6
14.9
9.94
9.87
kpa
0.05
16
108
5
29
1.78
0.65
1.6
1.5
—
—
—
0
0
5
29
1.78
0.65
1.6
1.5
—
—
—
0
0
5
29
1.78
0.65
1.6
1.5
—
—
—
0
0
37
312
1.39
0.64
2.2
2.3
5.13
5.40
mmol/l
1.07
32
283
16
115
1.51
0.64
3.4
4.4
4.83
2.41
e6/l
0.45
11
69
15
107
1.51
0.62
4.6
11.6
22.60
23.43
mmol/l
0.60
15
107
0
20
0.00
0.61
0.0
3.4
—
—
—
0
0
0
20
0.00
0.61
0.0
2.1
—
—
—
0
0
0
21
0.00
0.61
0.0
3.3
—
7.05
—
0
21
0
21
0.00
0.61
0.0
3.3
—
0.24
—
0
15
0
22
0.00
0.60
0.0
6.3
—
227.73
—
0
22
46
405
1.40
0.60
4.3
3.3
14.59
14.41
pmol/l
0.22
41
371
18
143
1.35
0.42
1.7
2.8
2.88
2.57
mg/l
0.23
13
124
31
269
1.27
0.39
7.2
8.5
6.70
5.86
mmol/l
0.77
31
251
9
69
1.35
0.39
1.1
1.3
—
—
—
0
0
18
146
1.31
0.37
2.9
2.5
—
—
—
0
0
12
93
1.35
0.32
1.2
1.4
109.40
95.36
pmol/l
—
5
53
58
550
1.32
0.31
14.5
10.4
19.33
23.03
mg/l
0.62
43
375
16
133
1.26
0.27
29.1
16.0
24.00
24.26
mmol/l
0.25
16
133
14
116
1.26
0.24
2.1
2.1
—
—
—
0
0
10
79
1.31
0.24
1.1
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
3.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
18
157
1.20
0.20
4.0
2.8
—
—
—
0
0
7
88
0.77
0.15
5.1
6.1
36.09
31.37
s
—
7
88
8
96
0.81
0.15
2.1
2.0
—
—
—
0
0
30
297
1.02
0.00
4.2
5.8
111.11
110.39
ml/min/173m2
0.05
20
185
58
585
0.95
0.00
4.6
3.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
5.72
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.0
—
1.26
—
0
6
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
10.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
18.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
7.80
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
1.54
—
0
6
5
50
1.00
-0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
7.07
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
147.88
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.92
-0.00
6.0
9.6
107.60
105.17
mmol/l
—
5
54
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
0.75
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
0.64
—
0
6
0
9
0.00
-0.00
0.0
3.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_FET_NEWB_COMPLICATIO_PLACEN_CORD_MEMBRANES and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_FET_NEWB_COMPLICATIO_PLACEN_CORD_MEMBRANES.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_FET_NEWB_COMPLICATIO_PLACEN_CORD_MEMBRANES – Fetus and newborn affected by complications of placenta, cord and membranes
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data